Joseph Dipoala
Internal Medicine · Rochester, NYNPI 1639124605
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,953 of the $7,518 with a category attached, or 65.9%. 34 manufacturers reported payments, led by Modernatx, Inc. at 46.3% of the total. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $29.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$3K
- Lilly USA, LLC$546
- AstraZeneca$447
- Pfizer$323
- GSK$282
- Novo Nordisk$259
- plus $2K from 28 others
Across 17 payments — averaging $1399.99 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$24K
What the payments were for
- Travel & lodging$2,55134%
- Food & beverage$4,95366%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 10 | $3,478 |
| Lilly USA, LLC | 38 | $546 |
| AstraZeneca | 26 | $447 |
| Pfizer | 31 | $323 |
| GSK | 19 | $282 |
| Novo Nordisk | 19 | $259 |
| Astellas Pharma US Inc | 9 | $252 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $240 |
| Nevro Corp. | 2 | $214 |
| Amgen | 10 | $186 |
| Johnson & Johnson | 13 | $176 |
| AbbVie(2 entities) | 9 | $167 |
| Merck | 9 | $120 |
| Boehringer Ingelheim | 6 | $110 |
| Amarin Pharma, Inc. | 5 | $104 |
| Novartis | 6 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $80 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Abbott | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Biogen | 2 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 1 | $26 |
| Alvogen Inc | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Mannkind Corporation | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Bayer | 1 | $13 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,518 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Rochester
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.